Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue

Williams, 2007, Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers, J. Proteome Res., 6, 2936, 10.1021/pr070041v Jelovac, 2011, Recent progress in the diagnosis and treatment of ovarian cancer, CA Cancer J. Clin., 61, 183, 10.3322/caac.20113 Rein, 2010, Potential markers for detection and monitoring of ovarian cancer, J Oncol, 2011, 475983 Jacob, 2009, Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs, Biomark. Med., 3, 743, 10.2217/bmm.09.48 Wiig, 2012, Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer, Physiol. Rev., 92, 1005, 10.1152/physrev.00037.2011 Haslene-Hox, 2011, A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue, PLoS One, 6, e19217, 10.1371/journal.pone.0019217 Faca, 2009, In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding, Cancer Res., 69, 728, 10.1158/0008-5472.CAN-08-3087 Simpson, 2008, Proteomics-driven cancer biomarker discovery: looking to the future, Curr. Opin. Chem. Biol., 12, 72, 10.1016/j.cbpa.2008.02.010 Teng, 2010, Advances in proximal fluid proteomics for disease biomarker discovery, J. Proteome Res., 9, 6091, 10.1021/pr100904q Sedlaczek, 2002, Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma, Cancer, 95, 1886, 10.1002/cncr.10917 Haslene-Hox, 2013, Interstitial fluid — a reflection of the tumor cell microenvironment and secretome, BBA — Proteins Proteomics, 10.1016/j.bbapap.2013.01.028 Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N. Engl. J. Med., 366, 883, 10.1056/NEJMoa1113205 Rein, 2011, Potential markers for detection and monitoring of ovarian cancer, J Oncol, 2011, 475983, 10.1155/2011/475983 Chechlinska, 2010, Systemic inflammation as a confounding factor in cancer biomarker discovery and validation, Nat. Rev. Cancer, 10, 2, 10.1038/nrc2782 Wiig, 2010, Interstitial fluid: the overlooked component of the tumor microenvironment?, Fibrogenesis Tissue Repair, 3, 12, 10.1186/1755-1536-3-12 Gromov, 2010, Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast, Mol. Oncol., 4, 65, 10.1016/j.molonc.2009.11.003 Raso, 2012, Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos Mass Spectrometry, and pathway analysis, J. Proteome Res., 11, 3199, 10.1021/pr2012347 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Kato, 2008, Critical roles of actin-interacting protein 1 in cytokinesis and chemotactic migration of mammalian cells, Biochem. J., 414, 261, 10.1042/BJ20071655 Wiig, 2003, Isolation of interstitial fluid from rat mammary tumors by a centrifugation method, Am. J. Physiol. Heart Circ. Physiol., 284, H416, 10.1152/ajpheart.00327.2002 Vaudel, 2011, SearchGUI: an open-source graphical user interface for simultaneous OMSSA and X!Tandem searches, Proteomics, 11, 996, 10.1002/pmic.201000595 Barsnes, 2011, compomics-utilities: an open-source Java library for computational proteomics, BMC Bioinformatics, 12, 70, 10.1186/1471-2105-12-70 Jensen, 2009, STRING 8—a global view on proteins and their functional interactions in 630 organisms, Nucleic Acids Res., 37, D412, 10.1093/nar/gkn760 Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B Methodol., 57, 289 Cox, 2008, MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification, Nat. Biotechnol., 26, 1367, 10.1038/nbt.1511 Gortzak-Uzan, 2008, A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers, J. Proteome Res., 7, 339, 10.1021/pr0703223 Hoskins, 2011, Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation, PLoS One, 6, e25056, 10.1371/journal.pone.0025056 Unwin, 2009, A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS), Nat. Protoc., 4, 870, 10.1038/nprot.2009.57 Visintin, 2008, Diagnostic markers for early detection of ovarian cancer, Clin. Cancer Res., 14, 1065, 10.1158/1078-0432.CCR-07-1569 Ahn, 2007, Body fluid proteomics: prospects for biomarker discovery, Proteomics Clin. Appl., 1, 1004, 10.1002/prca.200700217 Rifai, 2006, Protein biomarker discovery and validation: the long and uncertain path to clinical utility, Nat. Biotechnol., 24, 971, 10.1038/nbt1235 Sixt, 2007, Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?, Am. J. Physiol. Lung Cell. Mol. Physiol., 292, L1280, 10.1152/ajplung.00140.2006 Mueller, 2012, Circulating extracellular proteasome in the cerebrospinal fluid: a study on concentration and proteolytic activity, J. Mol. Neurosci., 46, 509, 10.1007/s12031-011-9631-2 Sixt, 2008, Extracellular, circulating proteasomes and ubiquitin — incidence and relevance, Biochim. Biophys. Acta, 1782, 817, 10.1016/j.bbadis.2008.06.005 Heubner, 2011, The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer, Gynecol. Oncol., 120, 233, 10.1016/j.ygyno.2010.10.014 Lavabre-Bertrand, 2001, Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies, Cancer, 92, 2493, 10.1002/1097-0142(20011115)92:10<2493::AID-CNCR1599>3.0.CO;2-F Maxwell, 2011, Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation, Gynecol. Oncol., 121, 586, 10.1016/j.ygyno.2011.02.031 Haab, 2010, Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms, Ann. Surg., 251, 937, 10.1097/SLA.0b013e3181d7738d Chou, 2003, Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin, Histopathology, 43, 151, 10.1046/j.1365-2559.2003.01687.x DiSaia, 1977, Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state, Cancer, 39, 2365, 10.1002/1097-0142(197706)39:6<2365::AID-CNCR2820390609>3.0.CO;2-I Blumenthal, 2007, Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers, BMC Cancer, 7, 2, 10.1186/1471-2407-7-2 Høgdall, 2008, Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study, Pathology, 40, 487, 10.1080/00313020802197889 Köbel, 2008, Ovarian carcinoma subtypes are different diseases: implications for biomarker studies, PLoS Med., 5, e232, 10.1371/journal.pmed.0050232 Boman, 2001, Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study, J. Pathol., 193, 339, 10.1002/1096-9896(2000)9999:9999<::AID-PATH798>3.0.CO;2-9 Albarracin, 2000, Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma, Hum. Pathol., 31, 672, 10.1053/hupa.2000.6799 Ji, 2002, Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas, Int. J. Gynecol. Pathol., 21, 391, 10.1097/00004347-200210000-00009 Sugai, 2008, Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors, Pathol. Int., 58, 681, 10.1111/j.1440-1827.2008.02293.x Samimi, 2007, Biomarkers of mucinous tumors of the ovary, Dis. Markers, 23, 389, 10.1155/2007/792356 Hornbeck, 2012, PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse, Nucleic Acids Res., 40, D261, 10.1093/nar/gkr1122 Dunham, 2012, Affinity-purification coupled to mass spectrometry: basic principles and strategies, Proteomics, 12, 1576, 10.1002/pmic.201100523